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Abstract
Background: The scientific and public debate concerning organized mammography screening is unprecedentedly
strong. With research evidence concerning its efficacy being ambiguous, the recommendations pertaining to the
age-thresholds for program inclusion vary between – and even within – countries. Data shows that young women
who are not yet eligible for systematic screening, have opportunistic mammograms relatively often and, moreover,
want to be included in organized programs. Yet, to date, little is known about the precise motivations underlying
young women’s desire and intentions to go for, not medically indicated, mammographic screening.
Methods: A cross-sectional online survey was carried out among women aged 30-49 years (n = 918) from Switzerland.
Results: The findings show that high fear (β = .08, p ≤ .05), perceived susceptibility (β = .10, p ≤ .05), and ego-
involvement (β = .34, p ≤ .001) are the main predictors of screening intentions among women who are not
yet eligible for the systematic program. Also, geographical location (Swiss-French group: β = .15, p ≤ .001;
Swiss-Italian group: β = .26, p ≤ .001) and age (β = .11, p ≤ .001) play a role. In turn, breast cancer knowledge,
risk perceptions, and educational status do not have a significant impact.
Conclusions: Young women seem to differ inherently from those who are already eligible for systematic
screening in terms of the factors underlying their intentions to engage in mammographic screening. Thus,
when striving to promote adherence to systematic screening guidelines – whether based on unequivocal
scientific evidence or policy decisions – and to allow women to make evidence-based, informed decisions
about mammography, differential strategies are needed to reach different age-groups.
Keywords: Breast cancer, Mammography screening, Knowledge, Fear, Risk perceptions, Ego-involvement,
Switzerland, Women aged 30-49
Background
Since the publication of the findings of the 25-year
Canadian National Breast Screening Study (CNBSS) in
February 2014, the scientific and public debate concern-
ing organized mammography screening has flared up.
The results of the CNBSS suggest that annual screening
of women aged 40 to 59 years does not reduce breast
cancer mortality beyond that of physical examination or
usual care and that, as a result, policy makers should ur-
gently reassess the rationale for mammography screen-
ing [1]. While the CNBSS has received considerable
methodological criticism [2–5], a recent evaluation re-
port issued by the International Agency for Research on
Cancer (IARC) draws similar conclusions. The IARC
work group evaluates that while the “efficacy of mam-
mographic screening in reducing mortality from breast
cancer is sufficient for women 50 to 69 years; efficacy
for women in other age groups is considered inad-
equate” [6]. Together, these findings seem to echo
Gøtzsche and Jørgensen’s 2013 Cochrane review, which
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states that the trade-offs of screening – such as over-
diagnosis, over-treatment, and psychological distress –
should be carefully considered in the decision to attend
or support screening programs among all age groups [7].
Currently, many countries in Western Europe and
North America offer organized breast cancer screening
programs. Reflecting the lack of scientific consensus
about screening efficacy, the precise recommendations
pertaining to the age-thresholds for program inclusion
vary. In the United States, the Preventive Services Task
Force advises women between the ages of 50 and 74 to
undergo a biennial screening mammography [8], while
the National Breast Cancer Early Detection Program es-
tablishes an eligibility baseline for breast cancer screen-
ing for women aged 40-64. The American Cancer
Society recommends yearly mammograms from the age
of 45. In Europe, the EU Council advocates early detec-
tion services to be offered on a two-year basis to women
aged 50 to 69 [9], but countries may implement these
recommendations as they see fit. While some countries,
like Norway, adhere to the thresholds as advised by the
EU Council [10], other countries have implemented
organized screening programs with more lenient age-
thresholds. For instance, in the Netherlands all women
between the ages of 50 and 75 are invited to participate
in a biennial, nationwide screening program [11]. In
Switzerland, programs are organized regionally. At
present, eleven out of the twenty-six cantons offer
screening programs to women over 50, with the age-
limit varying between 69 and 74 [12].
Recent studies suggest that, in the face of conflicting
research evidence and diverging recommendations,
young women (30-49) often do not accept the lower
age-thresholds for screening and advocate their right to
be included in organized screening programs [13–15]. In
fact, many young women already engage in opportunis-
tic screening. Data from the U.S. National Health Inter-
view Survey show that 29% of women aged 30-39 report
to have had a mammogram [16]. Moreover, data from
the 2010 Behavioral Risk Factor Surveillance Study re-
veal that 83% of women aged 40-49 have undergone
mammography screening [17]. In the Netherlands, 37%
of women aged 16 and over have had a mammogram in
the past two years [18]. The Swiss Federal Statistical Of-
fice reports that 44% of women aged 40-49 have under-
gone at least one mammogram, almost half of them in
the last two years [19]. Many of these women are un-
likely to exhibit symptoms and use mammography as a
mere precautionary measure.
There are several possible explanations for young
women to seek mammographic screening against official
recommendations and in absence of medical indications.
First, women may not be aware of the lower age-
thresholds. Breast cancer (screening) knowledge has
been shown to be one of the key predictors of screening
intentions among older women [20–23]. Second, ample
media coverage of the debate about breast cancer and
detection programs may in part induce erroneous beliefs
about screening and arouse anxiety – particularly among
women aged 40-49. For instance, Pink Ribbon Inter-
national, one of the most visible non-profit organizations
dedicated to raising breast cancer awareness and fund-
ing, explicitly advocates young women to have a screen-
ing mammogram: Triennially from the age of 20 and
biennially from the age of 40 onward [24]. Likewise,
public health efforts directed at convincing older women
to engage in mammographic screening may – as an acci-
dental byproduct – have motivated younger women to
go for screening. Induced by fear of breast cancer and
dying, an overestimation of their personal breast cancer
risk, and overconfidence in the potential of mammo-
graphic screening, young women consequently seem to
have adopted a perhaps overly positive attitude towards
early detection practices [25]. Schulz and Meuffels [13–
15] refer to such positive attitude based on perceived
personal relevance as high ego-involvement with mam-
mography screening.
To date, relatively little research has been done to in-
vestigate the precise motivations underlying young
women’s intentions to go for mammographic screening
prior to program eligibility [25]. Yet, such research is
crucial when striving, on the one hand, to enforce policy
decisions concerning the age-thresholds for systematic
screening programs and, on the other hand, to allow
young women to make evidence-based, informed deci-
sions about mammography, both now and in the future.
The present study, therefore, seeks to create a better un-
derstanding of young women’s motivations to engage in
early detection practices. Building on the findings of
prior studies, it reports on a survey that was conducted
across Switzerland, focused on young women’s know-
ledge, fear, risk perceptions, and ego-involvement as pos-
sible drivers to engage in medically unwarranted
mammographic screening before the age of 50.
Methods
Participants
In January 2015, a cross-sectional survey was conducted
across all Swiss cantons among a sample of 918 Swiss
female residents (i.e., in possession of a passport or resi-
dency permit), aged 30 to 49. Participants were recruited
in collaboration with Polyquest, a Swiss-based market
research agency that uses participant panels. The re-
sponse rate was relatively low (16.5%) and the drop-out
rate was high (26.25%). This was assumed to be due to
survey length and sensitivity of the topic. Moreover, it
was not allowed for participants to skip questions. While
it was not possible to access personal data of those who
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had interrupted the survey, the sample ensured to pro-
vide a reflection of this particular segment of the Swiss
population in terms of socio-demographics, including
age, marital status, education, occupational status, and
geographical location. For analytical purposes, the
French- and Italian-speaking regions of Switzerland were
oversampled relative to the German-speaking region.
The overall sample size was determined on the basis of
power calculations.
Prior to filling out the survey, participants were in-
formed that the study was aimed at improving the un-
derstanding of women’s views on and concerns about
breast cancer and organized mammographic screening
programs. Moreover, they were notified that the study
had been funded by the Swiss National Science Founda-
tion and that the protocol had been reviewed and, where
applicable, approved by the relevant ethical committees
(Swiss Ethics Committee for research involving humans;
Institutional Research Board of the University of
Lugano). As approved by the ethics committees and fol-
lowing standard practice of the surveying partner, all
participants provided informed consent within the on-
line surveying tool and selected their preferred surveying
language (French, German, or Italian) by clicking ‘next’.
The survey took approximately 30 min to complete and
had to be filled out in one sitting.
Survey development
The survey consisted of standardized socio-demographic
questions and validated scales. When necessary, the
measures were adapted or newly developed, e.g., to ac-
count for the Swiss breast cancer (screening) context.
All measures were translated from English to German,
French, and Italian using a back-translation procedure.
A pre-test (n = 22) confirmed the comprehensibility,
accuracy, and feasibility of the online questionnaire.
Breast cancer (screening) knowledge
To measure participants’ breast cancer knowledge, the
Comprehensive Breast Cancer Knowledge Test was
used [26, 27]. To match the purpose and context of
the study, the tool was adapted in several ways: items
pertaining to breast self-examination were removed;,
all items were reformulated into true/false questions
and updated to the contemporary Swiss context, and,
lastly five items concerning the organized Swiss
screening program were added.
Knowledge scores were computed for each of the sub-
scales and were expressed as the percentage of correctly
answered questions. Biserial correlations of each separ-
ate item with the total score of the subscale were com-
puted to determine the unidimensionality of each
subscale. Items belonging to the general knowledge,
curability, and Swiss screening program subscales all had
biserial correlations between .21 and .57 and were sig-
nificant at the p ≤ .01 level. These items were retained,
resulting. in a total pool of 25 binary items. To establish
the internal consistency reliability for the three
remaining subscales, the Kuder Richardson 20 (KR20)
statistic was used. This statistic provides an index of test
reliability for scales consisting of dichotomous items.
The internal consistency of the overall 25-item scale was
low, with KR20 = .36 (general knowledge, KR20 = .26;
curability KR20 = .46; Swiss program KR20 = .21).
Breast cancer fear
Breast cancer fear was assessed using the validated in-
strument developed by Champion and colleagues [28].
This measure consists of eight items, using a 5-point
Likert scale ranging from ‘strongly disagree’ to ‘strongly
agree,’ and taps into dimensions of fear such as anxiety,
depression, and uneasiness. Exploratory factor analysis
using principal axis factoring confirmed the validity of
the translated scale (KMO = .85), showing one factor,
explaining 67.6% of the variance. Furthermore, the trans-
lated scale had high internal consistency with a Cronbach’s
alpha of .94.. As such, these results demonstrated the
validity of the scale translation.
Risk perception
Participants’ risk estimates were measured in two ways.
Following Daly and colleagues [29], subjective risk per-
ception was measured by asking participants to rate
their chance of getting breast cancer someday on a scale
from 0% (no chance) to 100% (definitely will get it).
Additionally, a measure of perceived susceptibility to get
breast cancer was added: a 5-item, 5-point Likert scale
developed by Champion [31, 32]. Exploratory factor ana-
lysis with principal axis factoring (KMO = .85) confirmed
one factor, explaining 62.3% of the variance. Cronbach’s
alpha was .88.
Mammography screening involvement
Young women’s involvement with breast cancer screen-
ing practices was assessed using an adaptation of
Zaichkowsky’s personal involvement inventory – an atti-
tude measure based on semantic differentials [33]. While
Zaichkowsky’s scale was originally developed to be used
in the context of product purchases and advertising, it
adopts a general view of involvement that focuses on
personal relevance that is also largely applicable to
breast cancer screening practices. To ensure an opti-
mal contextual fit as well as to shorten the measure,
similarly to Zaichkowsky’s revised personal involve-
ment inventory [34], only half of the scale items were
used. An exploratory factor analysis was performed
using principal axis factoring (KMO = .96). The ana-
lysis confirmed one factor, explaining 62.8% of the
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variance. The scale demonstrated high internal consistency
with a Cronbach’s alpha of .94.
Mammography intentions
Participants’ intention to have a mammogram was mea-
sured in two ways. First, participants were asked to re-
spond to the statement “I intend to have (another)
screening mammogram to check for breast cancer in the
near future”, using a 5-point Likert scale (strongly dis-
agree - strongly agree), adding the option ‘I have not yet
thought about this’. Unless participants chose this last
option, they were additionally asked at what age - pro-
vided that their health status would remain the same –
they would consider to have a (next) mammogram.
Data analysis
Data were analyzed using the statistical package SPSS
(IBM, version 21). To test the associations between the
variables of interest, Pearson’s correlation coefficient was
used. Hierarchical multiple linear regression was per-
formed to adjust for potential confounders and to order
the importance of predictor variables. Variables were en-
tered block-wise and in hierarchical order, starting with
socio-demographic (control) variables (block 1), then
adding the presumed predictors in a step-by-step pro-
cedure based on theoretical assumptions of causality and
importance: perceived risk and susceptibility (block 2),
perceived fear (block 3), and ego-involvement and know-
ledge (block 4). The results of the regression are re-
ported with 95% confidence intervals and p-values. A
p-value of < .05 was considered as statistically significant.
Results
Sample
Participants were on average 39.37 years old (Md = 39,
Mo = 36, SD = 5.88, range: 30-49). 82.4% of participants
indicated to have the Swiss nationality. Overall, 59.9% of
participants hailed from the German-speaking region of
Switzerland, 29.8% from the French-speaking region,
and 10.2% from the Italian-speaking region. These num-
bers were reflected by participants’ choice of survey lan-
guage (German: 60.1%; French: 29.8%; Italian: 10%).
Cantons Zurich (14.1%), Berne (11.2%), and Vaud
(11.1%) were most represented. In terms of screening
availability, 52.18% of the participants lived in a canton
which offered a systematic screening program at the
time of the survey, while 47.82% lived in a canton offer-
ing opportunistic screening.
Most participants were married or in a stable relation-
ship (63.8%). 21.7% of the participants were single,
14.5% divorced, separated, or widowed. With regard to
their educational background, 8.3% of the participants
indicated to have a middle school degree, 62% a profes-
sional or high school degree, 15.4% a degree from a
university of applied sciences, and 14.2% a degree from a
(polytechnic) university. Of all participants, 0.2% indi-
cated not holding any degree. The majority of partici-
pants were (self )employed (57.6%). 25.4% of participants
were homemakers, 8.8% were unemployed (of which
7.6% in search of employment), 0.7% were students, and
finally 0.4% were pensioners.
Participants evaluated their overall health as relatively
good: On a scale ranging from 1 (“very poor”) to 5 (“very
good”), participants scored an average of 3.74 (SD = .88,
range: 1-5). As expected, having been diagnosed with a
chronic disease significantly impacted self-perceived
health (F(1, 892) = 129.39, p ≤ .001, η2 = .13). Further-
more, 27% of all participants indicated to have had a
mammogram in the past. Lastly, 58 participants had
been previously diagnosed with breast cancer (2.8%) or
with a genetic predisposition to get this disease (3.5%).
These participants were removed from the sample for
subsequent analyses. See Table 1 for an overview of the
sample description.
Descriptive statistics
Participants were relatively knowledgeable about breast
cancer and mammography screening. On average,
women answered 70.8% of the knowledge questions cor-
rectly, (Md = 72, Mo = 72, SD = 10.48), with a range be-
tween 28% and 96% corresponding to a minimum of
seven and a maximum of 24 correct answers. In terms
of general knowledge, women answered on average
66.9% of the questions correctly (Md = 66.7, Mo = 67,
SD = 14.42, range: 25%-100%). The scores for curability
knowledge were higher, with an average score of 78.1%
(Md = 75.0, Mo = 88, SD = 17.75, range: 0%-100%).
Lastly, with regard to Swiss program knowledge, women
scored on average 68.2% (Md = 80.0, Mo = 80, SD =
21.26, range: 0%-100%). Close examination of the indi-
vidual items revealed that while participants performed
well on most questions, notably some questions elicited
more erroneous than correct responses. These questions
pertained in particular to the risk factors for developing
breast cancer. Overall, participants displayed a lack of
knowledge of known risk factors, such as being over-
weight, living in a Western country, and age. More spe-
cifically: 54.1% of participants did not know that being
overweight is a risk factor for breast cancer; 56.3% of
women were not aware that breast cancer is more com-
mon in Switzerland than in Africa and Asia. Moreover,
52.9% of participants answered (erroneously) that
women without known risk factors rarely develop breast
cancer. Further, 57.3% did not know that breast cancer is
more prevalent under women aged 65 than 40. This lat-
ter finding was emphasized by the result that 42.1% of
participants thought that women over 70 rarely develop
breast cancer. In addition, 57.6% of women stated that
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mammograms are pain free. Lastly, participants were
unaware of the age-thresholds for organized screening in
Switzerland: The majority of participants (64.1%) an-
swered that Swiss programs invite women from the age
of 40 onward.
At the same time, participants appeared fearful of
breast cancer and over-estimated their risk of getting
breast cancer. On average, participants scored a 23.41
on the breast cancer fear scale, with scores ranging be-
tween eight and 40 (Md = 24.0, Mo = 24, SD = 7.64).
Overall, 13.7% of the participants were characterized
by low (score: ≤ 15), 30.2% by moderate (score: 16-
23), and 56% by high levels of fear (≥24). When asked
about their personal risk of developing breast cancer,
participants on average estimated this at 20.45% (Md =
20.0, Mo = 10, SD = 19.06, range: 0-100), equivalent to
a chance of 1 in 4.89. Participants’ self-perceived sus-
ceptibility to get breast cancer, however, was relatively
low with a mean score of 2.24 (Md = 2.20, Mo = 1,
SD = .82, range: 1-5).
Table 1 Sample description
Participants (N = 918) Number Percent M SD Range
Age – – 39.37 5.88 30-49
Marital status – – –
Married/stable relationship 586 63.8
Single 199 21.7
Divorced/separated/widowed 133 14.5
Education – – –
None 2 .02
Middle school 76 8.3
Professional or high school 569 62
University of applied sciences 141 15.4
University 130 14.1






Swiss nationality – – –
Yes 756 82.4
No 162 17.6




Systematic screening program – – –
Yes 479 52.2
No 439 47.8
Health status – – 3.74 .88 1-5
Genetic predisposition (e.g., BRCA1) 32 3.5 – – –
Breast cancer diagnosis 26 2.8
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Participants also appeared to be highly involved with
the topic of breast cancer screening (M= 5.40, Md = 5.5,
Mo = 7, SD = 1.12, range: 1-7). This implies that these
women deem mammography screening of very high
relevance to them personally and thus seem to have a
very positive attitude towards mammography screening
– despite their young age.
Finally, when asked to respond to the statement “I in-
tend to go for mammography screening in the near fu-
ture”, 87 participants (N = 860) indicated to not have
thought about that yet. Among those who responded to
the statement, 44.2% indicated to (strongly) disagree,
21.2% to neither agree nor disagree; and 34.5% to
(strongly) agree. On average, these respondents scored a
2.90 (Md = 3.0, Mo = 2, SD = 1.33, range: 1-5). When
asked at what age they intend to have their (next)
screening mammogram (N = 773), 272 women (35.2%)
answered they do not plan to have a mammogram at all.
The remaining women, indicated an average age for a
(next) mammogram of 45.50, with a mode of 50 (Md =
45.0, SD = 5.62, range: 31-80). In total, 56.7% of respon-
dents indicated the intention to have (another) screening
mammogram below the age of 50, thus below the lower
age threshold for systematic screening in Switzerland
(9.6% indicated an age below 40; 24.4% said 40-44; 22.8%
answered 45-49). In the Swiss-Italian region the indi-
cated average age was 44.10 (Md = 44.5, Mo = 40, SD =
6.89, range: 32-80), in the Swiss-German region 45.62
(Md = 46.0, Mo = 50, SD = 5.75, range: 32-60), and in the
Swiss-French region 45.84 (Md = 46.5, Mo = 50, SD =
4.85, range: 31-55).
Relationships between knowledge, attitudes, risk
perceptions, and intentions
In a first step, the strength of the relationships between
the variables of interest was tested. No meaningful asso-
ciations were found between breast cancer knowledge
and any of the other variables, including the main out-
come variable ‘mammography intentions’. This applied
to overall knowledge scores as well as to the three sub-
scales. Bivariate correlation analyses revealed a signifi-
cant, weak relationship between young women’s fear of
breast cancer and their risk perceptions, as such that
higher risk perceptions were associated with higher
levels of fear (r(858) = .24, p ≤ .001). Perceived suscepti-
bility to get breast cancer, as well, was strongly corre-
lated with breast cancer risk perceptions and fear
(r(858) = .54, p ≤ .001); (r(858) = .49, p ≤ .001), respect-
ively). Breast cancer fear and susceptibility, in turn, were
moderately correlated with participants’ ego-involvement
with breast cancer screening (r(858) = .32, p ≤ .001);
(r(858) = .30, p ≤ .001). That is, participants who perceived
themselves as fearful and highly susceptible to breast
cancer judged mammography as more relevant to them
personally and, thus, had a more positive attitude towards
screening. Finally, the intention to go for screening in the
near future was strongly associated with participants’ ego-
involvement (r(771) = .45, p ≤ .001), their perceived sus-
ceptibility (r(771) = .29, p ≤ .001), and fear (r(771) = .29,
p ≤ .001). The results show an association between partici-
pants’ involvement, fear, and perceived susceptibilityand
their intention to engage in screening in the near future.
In Table 2, an overview of the associations between the
different variables can be found.
Subsequently, a hierarchical multiple linear regression
analysis was used to test if knowledge, perceived breast
cancer risk and susceptibility, breast cancer fear, and
ego-involvement can indeed predict participants' inten-
tions to go for mammography screening. Participants’
age, educational levels, and geographical location were
controlled for as possible confounder variables. The re-
sults of the regression analysis demonstrate that three
main variables of interest, as well as two control vari-
ables, significantly predict mammography intention,
namely: ego-involvement (β = .34, p ≤ .001), breast cancer
fear (β = .08, p ≤ .05), perceived susceptibility (β = .10,
p ≤ .05), geographical location (Swiss-French group: β
= .15, p ≤ .001; Swiss-Italian group: β = .26, p ≤ .001), and
age (β = .11, p ≤ .001). Together, these variables explain
32% of the variance (R2 = .32, F(9, 772) = 38.78, p ≤ .001).
Breast cancer knowledge, risk perceptions, and educa-
tional status did not significantly contribute to the final
model (see Table 3).
Discussion
The results of the present study shed light on what mo-
tivates young healthy women to engage in premature op-
portunistic breast cancer screening. Some of the main
known predictors of breast cancer screening behaviors
among women who are eligible for screening were tested
for their explanatory potential among a young age
group. These predictors are: breast cancer knowledge,
breast cancer fear, perceived risk, and mammography in-
volvement – or attitude. In summary, it can be said that,
despite their relatively high levels of knowledge about
breast cancer, the young women in our sample display
high levels of breast cancer fear and tend to overesti-
mate their risk of getting this disease, even though the
objective risk within this particular age group without
respective genetic predispositions is low. Also, young
women’s ego-involvement with mammography screening
is high. That is, participants judge mammography
screening to be of high personal relevance and, thus,
have a positive attitude towards screening – in spite of
their young age. Even though overall screening inten-
tions are moderate, the majority of participants plan to
go for opportunistic screening before the age of 50.
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This study shows that breast cancer screening know-
ledge is neither associated with nor predictive of screen-
ing intentions among young women. This is remarkable,
because knowledge has been shown to be a good pre-
dictor of screening behaviors among women who are eli-
gible for screening. [20, 21, 23]. Breast cancer fear,
perceived susceptibility, and mammography involve-
ment, however, do predict screening intentions – as do
age and geographical location. Notably, Champion dem-
onstrates that while moderate fear can predict screening
behaviors, very high levels of fear can, in fact, prevent
eligible women from engaging in organized screening
[28]. Among the young age group, however, excess levels
of fear seem to cause early detection practices.
Remarkably, given their overall good knowledge about
breast cancer, women display a lack of knowledge of per-
sonal risk factors such as being overweight, older age,
and genetic predisposition. Moreover, they believe that
breast cancer is more common in Asia and Africa than
close to home in Switzerland. Simultaneously, young
women believe that mammograms are generally pain-
free and systematically used in Switzerland to detect
breast cancer among women aged 40 and over. On the
one hand, these results point to an optimistic bias per-
taining to the role of young Swiss women’s risk factors –
some of which are within control, such as weight. On
the other hand, the findings suggest that young Swiss
women overestimate the medical potential of organized
mammography screening. This may in part be caused by
what has been termed the popularity paradox of screen-
ing: The more women are over-diagnosed and over-
treated as a result of systematic early detection practices,
the stronger the general belief that screening is effective
in saving lives and the more popular screening programs
become [35]. This is strengthened by messages in the
media about improved survival statistics, which may in
reality be an artefact of over-diagnosis rather than
reduced mortality [36].
Taken together, the findings suggest that young
women’s breast cancer screening behaviors are mostly
motivated by emotional rather than rational factors. An
important question that remains is what precisely causes
young women’s elevated fear of breast cancer, their per-
ceived susceptibility to breast cancer, and their involve-
ment with mammography. Further studies, using more
sophisticated statistical modeling techniques, could ex-
plore the factors which influence young women’s breast
cancer fear and mammography involvement. Also, the
influence of the media on young women’s perceptions
and beliefs should be carefully examined. In addition,
the role of the health care providers in influencing
women’s decisions about mammographic screening
needs to be closely considered. Indeed, recent research
involving Australian breast screening experts, including
clinicians as well as researchers, shows that there is still
a lack of consensus on the experts’ side when it comes
to communication about and framing of over-diagnosis
as well as to the decision about how strongly women’s
choices should be guided by an expert [37, 38]. This dis-
agreement might be due to a different prioritization of
ethical and epistemological values that, in addition to
Table 2 Pearson’s correlation coefficient for the variables studied
Knowledge Fear Perceived risk Perceived susceptibility Ego-involvement
Knowledge –
Fear -.02 –
Perceived risk .01 .24*** –
Perceived susceptibility .04 .49*** .54*** –
Ego-involvement .07 .32*** .19 .30*** –
Mammography intention .02 .29*** .19 .29*** .45***
Note. ***Correlation significant at p ≤ 0.001. Only correlations above .20 have been considered for significance
Table 3 Coefficients variables resulting from hierarchical multiple
linear regression analysis (final model)
Model variables B SE β t p R R2 Adj. R2
Constant -1.27 .45 – -2.85 .008 – – –
Covariates
Age .025 .01 .11*** 3.69 .001 – – –
Education .075 .05 .05 1.53 .174 – – –
Region – – –
Swiss-Italian 1.12 .14 .26*** 8.14 .000
Swiss-French .43 .09 .15*** 4.65 .000
Predictors
Ego-involvement .40 .04 .34*** 10.2 .000 – – –
Knowledge -.27 .39 -.02 -.71 .389 – – –
Fear .02 .01 .08* 2.34 .013 – – –
Susceptibility .15 .06 .10* 2.36 .015 – – –
Risk .00 .00 .03 .94 .388 – – –
Model – – – – – .56 .32 .31
Note. B unstandardized regression coefficient, SE standard error, β standardized
regression coefficient, t obtained t-value, p probability, R2 proportion variance
explained, Adj. R2 adjusted proportion variance explained. Dependent variable:
mammography intentions in the near future. *Correlation significant at p ≤ 0.05.
**Correlation significant at p ≤ 0.01. ***Correlation significant at p ≤ 0.001
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medical evidence, can impact the experts’ opinions
about mammographic screening [37, 39].
Moreover, some of the present study’s findings warrant
further exploration of the impact of culture, policy-
making, and system factors on premature breast cancer
screening behaviors. Descriptive statistics showed that
Swiss-German participants’ are less likely to plan screen-
ing in the near future than Swiss-French and, particu-
larly, Swiss-Italian participants. This may be because of
cultural differences, as well regional differences in the
implementation of organized screening. These regional
variations were deemed beyond the scope of the present
study, yet of considerable importance for national public
health efforts. Therefore, a follow-up analysis has been
dedicated to exploring the impact of cultural affiliation
and program availability on screening perceptions and
practices across the Swiss cantons more thoroughly.
While the results of the present study form a solid
basis for further investigation, some limitations should
be considered. First, participants of this cross-sectional
survey were all members of Swiss survey panels and, as
a result, may not be strictly representative of the popula-
tion. This is a clear limitation. Moreover, in light of the
relatively low response rate and high drop-out rate, it
would have been particularly useful to compare those
participants that completed the survey to those that
did not. Second, the Comprehensive Breast Cancer
Knowledge scale displayed unfavorably low internal
consistency. Various authors have used (adaptations
of ) the Comprehensive Breast Cancer Knowledge Test
and have reported varying KR20 results [40, 41]. It is
possible that the scale adaptation and translation pro-
cedure have affected the low internal consistency of
the scale and, in turn, the study’s results. Items that
were relevant in the context of the original study may
have been, e.g., less applicable to Swiss participants.
Generally, it could be questioned whether a measure
of internal consistency is useful to assess the reliabil-
ity of a knowledge scale. After all, low internal
consistency does not necessarily imply low reliability.
While the scale findings thus have to be interpreted
with some caution, they were nonetheless considered
useful. When validating the present study, it would be
recommended to use additional measures of breast
cancer knowledge. Third, it was found that women’s
risk perceptions did not significantly predict screening
intentions and that, on average, women overestimated
their risk. This could imply that women have diffi-
culty to assess their risk numerically and that other
measurement types should be preferred [30]. Fourth,
as this is one of the first studies to quantitatively ex-
plore the factors underlying young women’s intentions
to go for pre-mature screening, it focused on known
predictors of mammography intentions among older
women. However other variables could also be considered
in future studies. Lastly, and perhaps most importantly, it
should be kept in mind that the present study does not
consider the legitimacy of women’s intentions. That is, as
this study focused on healthy young women’s motivations,
participants’ individual risk to develop breast cancer in the
future, as measured by a breast cancer risk assessment
tool [29], was not considered in the present study. Even
though all participants who had been formally diagnosed
with (a genetic predisposition to develop) breast cancer
were excluded from this study, some women may have in-
dicated a strong intention to go for screening in the near
future for medically valid reasons (e.g., a recent medical
exam or their family history).
Conclusion
While ample studies have been dedicated to identifying
the factors underlying women’s intentions to engage in
breast cancer screening, these studies have predomin-
antly focused on those women who are indeed eligible
for screening. Instead, this study investigates what moti-
vates young women’s premature opportunistic screening
behaviors among a sample of Swiss participants aged 30
to 49. This target group is of high relevance for several
reasons. As these women form the potential screening
population of the future, it is helpful to understand what
motivates their behavior prior to inclusion in systematic
screening programs. After all, these women are not only
exposed to extensive media coverage about breast cancer
(screening), but also to campaigns promoting mammog-
raphy screening among the actual target group. As such,
their opinions may be shaped by these campaigns and,
potentially and partially, be induced by fear. Data shows
that young women engage in opportunistic screening
relatively often and, moreover, are of the opinion that
they should be included in organized screening pro-
grams [13–15, 17, 19]. The influence of healthcare pro-
viders on young patients’ decisions and options about
this has thus far remained unclear. Yet, mammography
overuse can have serious consequences. In light of the
broad scientific, political, and public discussion about
the efficacy of screening, it is therefore of pivotal import-
ance that studies consider all age groups.
The present study demonstrates that young women
are indeed inherently different from women who are eli-
gible for screening in terms of what drives their mam-
mography behaviors. Among young women, breast
cancer fear, perceived susceptibility, and mammography
involvement were found to be the main predictors of
screening intentions. Breast cancer knowledge was not
found to be predictive of their intention to engage in
mammography. Additionally, young women did not al-
ways correctly identify breast cancer risk factors. Taken
together, this implies that in order to successfully
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promote adherence to screening guidelines – whether
these are based on unequivocal scientific evidence or
policy decisions – different public health communication
strategies must be developed for women of different age
groups. In doing so, efforts should be directed towards
informing young women about the correct age-
thresholds for mammography, correcting their erroneous
beliefs about breast cancer and screening, and reducing
excess levels of fear and involvement. Meanwhile, atten-
tion should be paid that women are not necessarily dis-
couraged to engage in organized screening once they
have reached program eligibility. To do so, public health
efforts should be supported by patients’ interpersonal
exchanges with their own providers. Overall, the findings
suggest that, rather than a rational and knowledge-
oriented approach, a targeted approach that takes young
women’s underlying motivational orientation and psy-
chological distance into account, could be promising
when designing interventions to justify and promote
public health decisions concerning the age-thresholds
for mammography. Moreover, effective communication
interventions will allow young women to make better-
informed decisions about screening, both now and in
the future.
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